Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variantsNga Bien‐Ly, Ryan J. Watts, Yang Yu et al.|The Journal of Experimental Medicine|2014Cited by 353
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic AntibodiesY. Joy Yu Zuchero, Ryan J. Watts, Xiaocheng Chen et al.|Neuron|2015Cited by 292
Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulationFan Liao, David M. Holtzman, Aimin Li et al.|Journal of Clinical Investigation|2018Cited by 186
Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonistAlexandra Litvinchuk, David M. Holtzman, Xin Bao et al.|Neuron|2023Cited by 133
Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonistAlexandra Litvinchuk, David M. Holtzman, Jung H. Suh et al.|Neuron|2024Cited by 18